THEuse of a radioactive compound as an aid to the diagnosis of an internal cancer would be highly desirable. Previous studies carried out in this laboratory have shown that with certain S35-labeled disulfonamido derivatives of fluorene and biphenyl there is an evident difference in the distribution of these compounds between tumor-bearing and tumor-free animal organisms. The most promising results have been obtained with disodium fluorene-2,7-disulfonate_S3.1 (Argus, 1953) and sulfonated derivative of fluorene-2,7-di(sulfonamido-2-naphthalene)_S35 (Argus and Hewson, 1954Hewson, ) 1955. Both compounds have been tested in tumor-bearing and tumor-free mice and at each time period studied (2, 8 and 32 hours) the ratios of localization in tumor tissue compared to the liver, spleen and also kidneys, blood and muscle were greatly increased.On the other hand, an interesting observation has been made with fluorene-2 7-di(sulfonamido-2-naphthalene)_S35 (Argus, Hewson and Ray, 1956) and biphenyl-4,4'-di(sulfonamido-benzene_S35-4-sulfonamide) (Argus, Seepe, Gutierrez, Hewson and Ray, 1958), which have been localized in the liver and spleen of tumor-free mice to a greater extent than in tumor-bearers.Fluorene-2,7-di(sulfonamido-2-naphthalene)_S35 showed the same behavior in hamsters with and without transplanted sarcoma (Argus, Lemasters, Gutierrez and Ray, 1957). Furthermore, when the tumors were removed the concentration of radioactivity in the liver and spleen returned to the level found in tumor-free animals. The same perception has been reported for male Wistar rats with Walker carcinosarcoma 256 (Argus, Seepe, Kane and Ray, 1958;Argus, 1961).To determine if, in the presence of tumor, the decreased uptake of fluorene-2, 7-di(sulfonamido-2-na,phthalene)_S35 by the liver and spleen is a general stress phenomenon, the distribution of this compound has been examined in rats and mice of both sexes after total whole body irradiation of 150 r (Argus, Kane and Ray, 1960) and after cortisone treatment (Malejka, Argus and Ray, 1961). The results of these experiments showed that the presence of tumor in animals is responsible for the differential uptake of disulfonamide by the liver and spleen. In the present study two new substances were prepared and examined in tumor-bearing and tumor-free Wistar rats in an attempt to find a favorable liverspleen or tumor localization. These were fluorene-2,7-di(sulfonamidobenzene-S35-* Post-Doctoral Fellow. Permanent address: